Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Net Cash Flow (2019 - 2026)

Fulcrum Therapeutics (FULC) has disclosed Net Cash Flow for 7 consecutive years, with $150.5 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 1143.52% to $150.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $139.3 million through Dec 2025, up 325.3% year-over-year, with the annual reading at $139.3 million for FY2025, 325.3% up from the prior year.
  • Net Cash Flow for Q4 2025 was $150.5 million at Fulcrum Therapeutics, up from $4.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $150.5 million in Q4 2025, with the low at -$55.8 million in Q4 2022.
  • Average Net Cash Flow over 5 years is $7.0 million, with a median of -$566000.0 recorded in 2023.
  • Peak annual rise in Net Cash Flow hit 6189.58% in 2024, while the deepest fall reached 262.51% in 2024.
  • Over 5 years, Net Cash Flow stood at -$30.1 million in 2021, then plummeted by 85.76% to -$55.8 million in 2022, then soared by 91.91% to -$4.5 million in 2023, then plummeted by 219.19% to -$14.4 million in 2024, then surged by 1143.52% to $150.5 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $150.5 million, $4.5 million, and $414000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.